PLRX vs WRK
Pliant Therapeutics Inc (PLRX) versus WRK (WRK) — a side-by-side from cached financials, not a winner call.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
WRK (WRK) common stock.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
WRK does not have a complete income-statement cache yet.
PLRX currently screens at market cap $77.3M.
Not investment advice. Open the PLRX and WRK stock pages for the full models.
Not investment advice.